Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies.

ABSTRACT:

SUBMITTER: Zhang J 

PROVIDER: S-EPMC8323704 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature